Bank of Montreal’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215M Sell
7,667,405
-1,975,174
-20% -$52.6M 0.08% 199
2025
Q4
$240M Buy
9,642,579
+400,114
+4% +$10.1M 0.08% 187
2025
Q3
$235M Buy
9,242,465
+636,397
+7% +$15.7M 0.09% 166
2025
Q2
$209M Sell
8,606,068
-1,186,269
-12% -$27.7M 0.1% 150
2025
Q1
$248M Sell
9,792,337
-969,442
-9% -$25.4M 0.12% 139
2024
Q4
$286M Sell
10,761,779
-4,605,455
-30% -$125M 0.13% 130
2024
Q3
$447M Buy
15,367,234
+287,512
+2% +$8.39M 0.2% 95
2024
Q2
$426M Buy
15,079,722
+224,272
+2% +$6.17M 0.12% 100
2024
Q1
$413M Buy
14,855,450
+1,482,055
+11% +$41.1M 0.13% 104
2023
Q4
$399M Sell
13,373,395
-3,473,979
-21% -$105M 0.12% 99
2023
Q3
$623M Buy
16,847,374
+2,432,254
+17% +$86M 0.22% 62
2023
Q2
$579M Buy
14,415,120
+2,487,958
+21% +$96.8M 0.2% 64
2023
Q1
$587M Sell
11,927,162
-1,523,508
-11% -$65.8M 0.23% 61
2022
Q4
$722M Buy
13,450,670
+1,417,953
+12% +$68M 0.31% 44
2022
Q3
$592K Sell
12,032,717
-595,208
-5% -$28.9M 0.26% 52
2022
Q2
$655K Sell
12,627,925
-1,612,376
-11% -$82.2M 0.3% 57
2022
Q1
$757M Buy
14,240,301
+858,254
+6% +$44.5M 0.37% 58
2021
Q4
$786M Sell
13,382,047
-4,283,139
-24% -$212M 0.42% 47
2021
Q3
$777M Buy
17,665,186
+5,450,866
+45% +$241M 0.35% 56
2021
Q2
$483M Buy
12,214,320
+1,579,179
+15% +$61.4M 0.24% 84
2021
Q1
$382M Sell
10,635,141
-42,503
-0.4% -$1.51M 0.25% 80
2020
Q4
$403M Buy
10,677,644
+763,978
+8% +$28M 0.27% 83
2020
Q3
$340M Sell
9,913,666
-914,410
-8% -$32.1M 0.28% 77
2020
Q2
$344M Sell
10,828,076
-546,530
-5% -$18.6M 0.31% 68
2020
Q1
$355M Sell
11,374,606
-4,629,695
-29% -$158M 0.41% 55
2019
Q4
$595M Sell
16,004,301
-641,928
-4% -$22.9M 0.45% 43
2019
Q3
$567M Sell
16,646,229
-1,510,065
-8% -$54.9M 0.49% 42
2019
Q2
$746M Sell
18,156,294
-52,788
-0.3% -$2.1M 0.63% 31
2019
Q1
$734M Sell
18,209,082
-2,083,724
-10% -$83.4M 0.63% 29
2018
Q4
$840M Sell
20,292,806
-2,922,826
-13% -$121M 0.79% 22
2018
Q3
$971M Buy
23,215,632
+311,567
+1% +$12M 0.76% 22
2018
Q2
$788M Sell
22,904,065
-535,502
-2% -$18.3M 0.65% 30
2018
Q1
$789M Buy
23,439,567
+4,895,690
+26% +$168M 0.7% 27
2017
Q4
$637M Buy
18,543,877
+383,261
+2% +$13.1M 0.55% 34
2017
Q3
$615M Sell
18,160,616
-1,374,388
-7% -$44.2M 0.56% 30
2017
Q2
$623M Buy
19,535,004
+233,811
+1% +$7.37M 0.6% 28
2017
Q1
$626M Buy
19,301,193
+1,130,180
+6% +$35.6M 0.59% 29
2016
Q4
$554M Sell
18,171,013
-1,932,291
-10% -$59M 0.58% 28
2016
Q3
$646M Sell
20,103,304
-1,324,024
-6% -$44.3M 0.71% 25
2016
Q2
$716M Buy
21,427,328
+2,714,696
+15% +$86.6M 0.82% 23
2016
Q1
$526M Sell
18,712,632
-599,114
-3% -$17.1M 0.56% 30
2015
Q4
$591M Sell
19,311,746
-1,065,418
-5% -$33.5M 0.71% 21
2015
Q3
$607M Buy
20,377,164
+6,832,832
+50% +$219M 0.84% 20
2015
Q2
$431M Sell
13,544,332
-35,945
-0.3% -$1.17M 0.5% 32
2015
Q1
$448M Sell
13,580,277
-6,789,299
-33% -$216M 0.52% 31
2014
Q4
$602M Buy
20,369,576
+4,165,053
+26% +$119M 0.68% 24
2014
Q3
$455M Sell
16,204,523
-465,477
-3% -$13.1M 0.51% 33
2014
Q2
$469M Buy
16,670,000
+755,322
+5% +$21.5M 0.52% 34
2014
Q1
$485M Sell
15,914,678
-1,078,248
-6% -$32.1M 0.63% 28
2013
Q4
$494M Buy
16,992,926
+2,826,632
+20% +$82.3M 0.68% 28
2013
Q3
$386M Buy
14,166,294
+860,557
+6% +$23.4M 0.6% 32
2013
Q2
$354M Buy
+13,305,737
New +$368M 0.63% 31

Other funds holding PFE

Bank of Montreal's PFE Position: Q1 2026 in Review

Bank of Montreal reduced its Pfizer (PFE) stake by 20% in Q1 2026, selling an estimated $52.6M and leaving 7,667,405 shares worth $215M. The position accounts for 0.08% of the portfolio, ranked #199.

Bank of Montreal first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $971M in Q3 2018. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bank of Montreal held 7,667,405 shares of Pfizer worth $215M as of Q1 2026.
  • Bank of Montreal sold 1,975,174 Pfizer shares in Q1 2026, an estimated $52.6M.
  • Pfizer made up 0.08% of Bank of Montreal's portfolio in Q1 2026, its #199 holding.
  • Bank of Montreal first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Pfizer position peaked at $971M in Q3 2018.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.